NLBIF News and Press, New Age Brands From 08/12/20

DENVER, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" “MIG” or the "Company"), is pleased to provide a corporate update regarding recent advancements and achievements that continues to add shareholder value and ...

DENVER, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group™ (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) ("Mydecine"), is pleased to announce that its subsidiary, Mindleap Health ™ (“Mindleap” or the “Company”) based in Vancouver, British Columbi...

DENVER , July 24, 2020 /PRNewswire/ -- Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE: 0NF) ("Mydecine" or the "Company"), is pleased to announce that they have hired former Red Bull marketing executive, Jim Gunning , as the Company's new Chief Marketing Officer ("CMO")....

Mindleap Health Signs Agreement with Brightmind to Launch Comprehensive Meditation Program Canada NewsWire DENVER, July 21, 2020 DENVER , July 21, 2020 /CNW/ -- Mydecine Innovations Group Inc. (CSE: MYCO) (OTCMKTS: MYCOF) (FSE: 0NF) ("Mydecine" or the "Company") is please...

DENVER , July 16, 2020 /PRNewswire/ -- Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce that, further to its press release of July 14, 2020 , its prospective acquisition target NeuroPharm Inc. ("NeuroPharm"), a devel...

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans Canada NewsWire DENVER, July 14, 2020 DENVER , July 14, 2020 /CNW/ -- Mydecin...

DENVER , July 14, 2020 /PRNewswire/ --  Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce that, further to its press release on June 10, 2020 , it has entered into a definitive share exchange agreement (the ...

Mydecine Innovations Group Adds World Renowned, 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to Its Scientific Advisory Board Canada NewsWire VANCOUVER, British Columbia, July 7, 2020 VANCOUVER, British Columbia , July 7, 2020 /CNW/ -- Mydecine Innovations Group Inc. (C...

VANCOUVER, British Columbia , July 7, 2020 /PRNewswire/ -- Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), announced today that seven-time Nobel Prize-nominated scientist Dr. Malireddy Srinivasulu Reddy will be joining the Mydecine team as...

Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board Canada NewsWire VANCOUVER, British Columbia, June 30, 2020 VANCOUVER, British Columbia , June 30, 2020 /CNW/ -- Mydecine Innovations Group Inc. (CSE: MYCO) (OT...